Friday, October 16, 2020

1:00-6:00pm

4th International Bladder Cancer Update

Registration and Exhibitor Check-in

1:55-2:00pm

Welcome and Introduction
Michael S. Cookson and Daniel Petrylak, MD

2:00-2:30pm

SWOG Contributions to Bladder Cancer
E. David Crawford, MD

2:30-3:00pm

Keynote Speaker: Immunotherapy in Bladder Cancer
Donald Lamm, MD

3:00-3:30pm

Variant Histology
Donna Hansel, MD

3:30-4:00pm

TCGA and Molecular Staging
Seth P. Lerner, MD

4:00-4:30pm

BCAN: Evolution of Advocacy and Research
Gary D. Steinberg, MD

4:30-5:00pm

COXIN Update
Dan Theodurescu, MD, PhD

5:00-5:30pm

Microhematuria: Cost-Effective Workup
Eugene Rhee, MD

6:00-7:00pm

IBCU Welcome Reception
Exhibit Hall

7:00-8:00pm

IBCU Poster Session
Exhibit Hall

Saturday, October 17, 2020

7:00am-8:00am

Educational Breakfast Symposium
TBD

8:00am-11:00am

SESSION I: Management of Non-Muscle Invasive Bladder Cancer
 

8:00am-8:10am

Welcome and Introduction
Michael S. Cookson, MD, MMHC

8:10am-8:30am

Controversies in NMIBC: Guidelines and Beyond
“Michael S. Cookson, MD, MMHC

8:30am-8:50am

Use of Biomarkers in NMIBC: What’s New?
Peter Black, MD

8:50am-9:10am

BCG Shortage: Optimal Treatment Strategies During a Time of Crisis
Sanjay G. Patel, MD

9:10am-9:20am

Break and Visit Exhibits
 

9:20am-9:50am

T1 Bladder Cancer
Ashish M. Kamat, MD

9:50am-10:10am

BCG Unresponsive NMIBC: What’s Available Today?
Ashish M. Kamat, MD, MBBS, FACS

10:10am-10:30am

Enhanced Imaging Techniques and Quality Indicators of TURBT
Neal D. Shore, MD

10:30am-11:00am

Panel Discussion/Questions and Answers
 

11:00am-12:00pm

Session II: Challenging Case Presentations
Moderator: Sanjay G. Patel, MD
Panelists: Neal D. Shore, Peter Black, Seth P. Lerner, Ashish M. Kamat

12:00pm-1:00pm

Educational Lunch Symposium
Supported by Janssen

1:00pm-2:40pm

Session III: Advanced Urothelial Cancer Part 1 – Impact on the Urologist’s Practice
 

1:00pm-1:20pm

Urology Professionals at the Forefront of Bladder Cancer Care: Getting a Grip on the Evolving Role of Immune Checkpoint Inhibitors
Arjun V. Balar, MD

1:20pm-1:40pm

Immune Checkpoint Inhibitors: How Will They Impact Urology Practice?
Neal D. Shore, MD

1:40pm-2:00pm

Immune Checkpoint Inhibitors: How Will They Impact Urology Practice?
Gary D. Steinberg, MD

2:00pm-2:40pm

Immune Therapy Panel Discussion/Questions and Answers
Moderator: Arjun V. Balar, MD
Panelists: Neal D. Shore, Gary D. Steinberg, Dan Theodorescu

2:40pm-3:00pm

Break and Exhibits
 

3:00pm-4:30pm

SESSION III: Advanced Urothelial Cancer Part 2 – Latest Research and Clinical Trials
 

3:00pm-3:20pm

Novel Gene Therapies for Patients with High-Grade, BCG-Refractory, or Relapsed Non-Muscle-Invasive Bladder Cancer
Stephen A. Boorjian, MD

3:20pm-3:40pm

FGFR Kinase Inhibitors in the Treatment of Metastatic Urothelial Cancer
Ashish M. Kamat, MD, MBBS, FACS

3:40pm-4:00pm

The Use of Antibody-Drug Conjugates in Treating Advanced Urothelial Cancer
Daniel P. Petrylak, MD

4:00pm-4:30pm

Research Panel Discussion/Questions and Answers
Moderator: Dan Theodorescu, MD, PhD
Panelists: Ashish M. Kamat, Neal D. Shore, Daniel P. Petrylak, and Stephen A. Boorjian

5:00pm-7:00pm

IBCU Sponsored Event (TBD)

Sunday, October 18, 2020

7:00am-8:00am

Educational Breakfast Symposium
TBD

8:00am-9:00am

Session IV: Management of UTUC

8:00am-8:20am

Methods and Guidelines to Stage and Grade (Low vs. High) UTUC
Dan Theodorescu, MD, PhD

8:20am-8:40am

Treatment of Advanced UTUC
Seth P. Lerner, MD

8:40pm-9:00pm

Advanced Disease Panel Discussion/Questions and Answers
Moderator: Daniel P. Petrylak
Panelists: Seth P. Lerner, Stephen A. Boorjian, Dan Theodorescu, Ashish M. Kamat, Arjun V. Balar

9:00am-10:30am

Session V: Management of MIBC

9:00am-9:20am

MIBC Guidelines Review
Michael S. Cookson, MD, MMHC, FACS

9:20am-9:40am

Perioperative Pathways: What We Know Works
Peter Black, MD

9:40pm-10:00am

Lymphadenectomy in Invasive Bladder Cancer: Knowns and Unknowns
Seth P. Lerner, MD

10:00am-10:30pm

Invasive Panel Discussion/Questions and Answers
Moderator: Gary D. Steinberg, MD
Panelists: Peter Black, Seth P. Lerner, Sanjay G. Patel, Ashish M. Kamat

10:30am

Closing Remarks and Adjourn

Media Partner

Bladder Cancer Journal

Bladder Cancer is an international multidisciplinary journal published by IOS Press. It facilitates progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pharmacology, ethics, patient advocacy and survivorship, diagnosis and treatment of tumors of the bladder and upper urinary tract. The journal’s Editors-in-Chief are Seth P. Lerner, MD (Baylor College of Medicine, Houston, TX, USA) and Dan Theodorescu, MD, PhD (University of Colorado Cancer Center, Aurora, CO, USA). Included in the quarterly publication are research reports, reviews, short communications, and letters-to-the-editor. In addition, the journal will also have a “News and Views” section for timely commentary. Launched in 2015, the journal is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of tumors of the bladder and upper urinary tract.